APA
Sen H., Lam M. K., Tandjung K., Basalus M. W. Z., de Man F. H. A. F., Louwerenburg J. H. W., Stoel M. G., van Houwelingen G. K., Löwik M. M., Linssen G. C. M., Saïd S. A. M., Nienhuis M. B., Verhorst P. M. J., van der Palen J. & von Birgelen C. (20150710). Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial. : EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
Chicago
Sen Hanim, Lam Ming Kai, Tandjung Kenneth, Basalus Mounir W Z, de Man Frits H A F, Louwerenburg J Hans W, Stoel Martin G, van Houwelingen Gert K, Löwik Marije M, Linssen Gerard C M, Saïd Salah A M, Nienhuis Mark B, Verhorst Patrick M J, van der Palen Job and von Birgelen Clemens. 20150710. Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial. : EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
Harvard
Sen H., Lam M. K., Tandjung K., Basalus M. W. Z., de Man F. H. A. F., Louwerenburg J. H. W., Stoel M. G., van Houwelingen G. K., Löwik M. M., Linssen G. C. M., Saïd S. A. M., Nienhuis M. B., Verhorst P. M. J., van der Palen J. and von Birgelen C. (20150710). Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial. : EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
MLA
Sen Hanim, Lam Ming Kai, Tandjung Kenneth, Basalus Mounir W Z, de Man Frits H A F, Louwerenburg J Hans W, Stoel Martin G, van Houwelingen Gert K, Löwik Marije M, Linssen Gerard C M, Saïd Salah A M, Nienhuis Mark B, Verhorst Patrick M J, van der Palen Job and von Birgelen Clemens. Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial. : EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 20150710.